Skip to main content
Equibles

Jay S. Duker

Carisma Therapeutics Inc.

CEO

EyePoint, Inc. (EYPT)
EyePoint, Inc. (EYPT)

Board Member

EyePoint, Inc. (EYPT)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jay S. Duker

Jay S. Duker is recorded as CEO and Board Member at EyePoint, Inc. (EYPT). EyePoint, Inc. reported in an 8-K filed July 10, 2023 that Jay S. Duker was appointed Director, effective July 10, 2023. EyePoint, Inc. reported in an 8-K filed July 10, 2023 that Jay S. Duker was appointed President and Chief Executive Officer, effective July 10, 2023. Carisma Therapeutics Inc. reported in an 8-K filed March 8, 2023 that Jay S. Duker resigned as Board, effective March 7, 2023.

“(ii) appointed Dr. Duker to fill the vacancy for the newly created directorship resulting from the increase in the number of directors, to serve until the Company's 2024 annual meeting of stockholders and until his successor has been designated or appointed and qualified, as the case may be, or until his earlier death, resignation or removal.”
EyePoint, Inc. Form 8-K, filed July 10, 2023 · Read the filing
“the Company appointed Dr. Duker as the Company's President and Chief Executive Officer, effective as of July 10, 2023 (the "Duker Start Date").”
EyePoint, Inc. Form 8-K, filed July 10, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Carisma Therapeutics Inc.

Current role

Leadership on record at EyePoint, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.